BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34922588)

  • 1. Efficacy of Guizhi Fuling Wan for primary dysmenorrhea: protocol for a randomized controlled trial.
    Du Y; Li Y; Fu X; Li C; Yanan L
    Trials; 2021 Dec; 22(1):933. PubMed ID: 34922588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Guizhi Fuling Wan in primary dysmenorrhea: A randomized controlled trial.
    Luo Y; Mao P; Chen P; Li C; Fu X; Zhuang M
    J Ethnopharmacol; 2023 May; 307():116247. PubMed ID: 36746293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese herbal formula Xuefu Zhuyu for primary dysmenorrhea patients (CheruPDYS): a study protocol for a randomized placebo-controlled trial.
    Li G; Zhang Z; Zhou L; Liao S; Sun J; Liu Y; Wang X; Wen Z
    Trials; 2021 Jan; 22(1):95. PubMed ID: 33499921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acupoint herbal plaster for patients with primary dysmenorrhea: study protocol for a randomized controlled trial.
    Yu S; Wen Y; Xia W; Yang M; Lv Z; Li X; Li W; Yang S; Hu Y; Liang F; Yang J
    Trials; 2018 Jul; 19(1):348. PubMed ID: 29970155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of different forms of Guizhi Fuling Wan on reproduction and metabolism in women with polycystic ovary syndrome: A protocol for a meta-analysis of randomized controlled trials.
    Liu M; Zhu H; Hu X; Zhu Y; Chen H
    Medicine (Baltimore); 2020 Oct; 99(44):e22954. PubMed ID: 33126363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind trial comparing low dose and conventional dose of a modified traditional herbal formula Guizhi Fuling Wan in women with symptomatic uterine fibroids.
    Meng W; Lin WL; Yeung WF; Zhang Y; Ng EHY; Lee YPE; Zhang ZJ; Rong J; Lao L
    J Ethnopharmacol; 2022 Jan; 283():114676. PubMed ID: 34562564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects and safety of varying doses of guizhi fuling capsule in patients with primary dysmenorrhea: a multi-center, randomized, double-blind, placebo-controlled clinical study].
    Liu YJ; Xiao W; Wang ZZ; Zhao BJ; Zhou ZM; Jiang HZ; Jin Z; Wei SB; Wang Z; Wang DM; Xia QH; Lin J; Wang Q
    Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(12):2019-22. PubMed ID: 24066604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Mechanisms of Guizhi Fuling Wan in Treating Endometriosis: An Analysis Based on TCMSP and DisGeNET Databases.
    Yee JL; Huang CY; Yu YC; Huang SJ
    J Ethnopharmacol; 2024 Jul; 329():118190. PubMed ID: 38614264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese herbal formula siwutang for treating primary dysmenorrhea: A systematic review and meta-analysis of randomized controlled trials.
    Li G; Liu A; Lin M; Liao S; Wen Z
    Maturitas; 2020 Aug; 138():26-35. PubMed ID: 32631585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manual acupuncture versus sham acupuncture and usual care for the prevention of primary dysmenorrhea (PD): study protocol for a randomized controlled trial.
    Yu L; Liu S; Zheng C; Liu W; Wang H; Liang F; Lu W; Xu S; Wang W
    Trials; 2020 Sep; 21(1):818. PubMed ID: 32993752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatory effects of current regimens and Guizhi Fuling Wan on the development of endometriosis.
    Chen CC; Huang CY; Shiu LY; Yu YC; Lai JC; Chang CC; Fu CF; Huang SJ
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):70-74. PubMed ID: 35181049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism Study on Danggui Shaoyao San and Guizhi Fuling Wan For Treating Primary Dysmenorrheal Based on Biological Network].
    Wang YL; Ru SY; Fang Q; Li GQ; Pan YF; Yao Y; Xu F
    Zhong Yao Cai; 2015 Nov; 38(11):2348-52. PubMed ID: 27356390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and cerebral mechanism of acupuncture and moxibustion for treating primary dysmenorrhea: study protocol for a randomized controlled clinical trial.
    Dong X; Yang J; Wei W; Chen L; Su M; Li A; Guo X; Liu L; Li S; Yu S; Zeng F
    Trials; 2022 Nov; 23(1):964. PubMed ID: 36443858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of moxibustion to treat primary dysmenorrhea at two interventional times: study protocol for a randomized controlled trial.
    Yang J; Yu S; Lao L; Yang M; Chen J; Luo X; Wang Y; Chen X; Li J; Zhu L; Zheng Q; Hu Y; Wu X; Liang F
    Trials; 2015 Jan; 16():35. PubMed ID: 25633584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gyejibongneyong-hwan, a herbal medicine for the treatment of dysmenorrhoea with uterine fibroids: a protocol for a randomised controlled trial.
    Jung J; Lee JA; Ko MM; You S; Lee E; Choi J; Kang BK; Lee MS
    BMJ Open; 2016 Nov; 6(11):e013440. PubMed ID: 27884853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese herbal medicine Guizhi Fuling Formula for treatment of uterine fibroids: a systematic review of randomised clinical trials.
    Chen NN; Han M; Yang H; Yang GY; Wang YY; Wu XK; Liu JP
    BMC Complement Altern Med; 2014 Jan; 14():2. PubMed ID: 24383676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of traditional Chinese medicine formula GeGen decoction on primary dysmenorrhea: A randomized controlled trial study.
    Chai C; Hong F; Yan Y; Yang L; Zong H; Wang C; Liu Z; Yu B
    J Ethnopharmacol; 2020 Oct; 261():113053. PubMed ID: 32534120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of integrative evidence chain in clinical trial of Guizhi Fuling Capsules based on "Yibing Tongzhi" in clinical applications].
    Gao Y; Wang GQ; Xie YM; Wei RL; Liu FM
    Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2304-2309. PubMed ID: 32495585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats.
    Cheng Y; Chu Y; Su X; Zhang K; Zhang Y; Wang Z; Xiao W; Zhao L; Chen X
    Phytomedicine; 2018 Sep; 48():141-151. PubMed ID: 30195872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroacupuncture treatment of primary dysmenorrhea: A randomized, participant-blinded, sham-controlled clinical trial protocol.
    Xue X; Liu X; Pan S; Li J; Wang S; Yuan H; Liu Y; Yue Z
    PLoS One; 2023; 18(5):e0282541. PubMed ID: 37235569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.